{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:13:54Z","timestamp":1790673234940,"version":"4.1.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Background and Aims:<\/jats:bold>Acute coronary syndrome (ACS) is a group of clinical syndromes characterized by rupture or erosion of atherosclerotic unstable plaques. Effective intervention for vulnerable plaques (VP) is of great significance to reduce adverse cardiovascular events.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold>Fbn1<jats:sup>C1039G+\/\u2212<\/jats:sup>mice were crossbred with LDLR<jats:sup>\u2212\/\u2212<\/jats:sup>mice to obtain a novel model for atherosclerotic VP. After the mice were fed with a high-fat diet (HFD) for 12 or 24 weeks, pathological staining and immunohistochemistry analyses were employed to evaluate atherosclerotic lesions.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold>Compared to control mice, Fbn1<jats:sup>C1039G+\/\u2212<\/jats:sup>LDLR<jats:sup>\u2212\/\u2212<\/jats:sup>mice developed more severe atherosclerotic lesions, and the positive area of oil red O staining in the aortic sinus was significantly increased after 12 weeks (21.7 \u00b1 2.0 vs. 6.3 \u00b1 2.1) and 24 weeks (32.6 \u00b1 2.5 vs. 18.7 \u00b1 2.6) on a HFD. Additional vulnerable plaque characteristics, including significantly larger necrotic cores (280 \u00b1 19 vs. 105 \u00b1 7), thinner fiber caps (14.0 \u00b1 2.8 vs. 32.6 \u00b1 2.7), apparent elastin fiber fragmentation and vessel dilation (3,010 \u00b1 67 vs. 1,465 \u00b1 49), a 2-fold increase in macrophage number (8.5 \u00b1 1.0 vs. 5.0 \u00b1 0.6), obviously decreased smooth muscle cell number (0.6 \u00b1 0.1 vs. 2.1 \u00b1 0.2) and an ~25% decrease in total collagen content (33.6 \u00b1 0.3 vs. 44.9 \u00b1 9.1) were observed in Fbn1<jats:sup>C1039G+\/\u2212<\/jats:sup>LDLR<jats:sup>\u2212\/\u2212<\/jats:sup>mice compared with control mice after 24 weeks. Furthermore, spontaneous plaque rupture, neovascularization, and intraplaque hemorrhage were detected in the model mouse plaque regions but not in those of the control mice.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold>Plaques in Fbn1<jats:sup>C1039G+\/\u2212<\/jats:sup>LDLR<jats:sup>\u2212\/\u2212<\/jats:sup>mice fed a HFD show many features of human advanced atherosclerotic unstable plaques. These results suggest that the Fbn1<jats:sup>C1039G+\/\u2212<\/jats:sup>LDLR<jats:sup>\u2212\/\u2212<\/jats:sup>mouse is a novel model for investigating the pathological and physiological mechanisms of advanced atherosclerotic unstable plaques.<\/jats:p>","DOI":"10.3389\/fcvm.2021.642751","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T04:20:52Z","timestamp":1615868452000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Establishment of a Novel Mouse Model for Atherosclerotic Vulnerable Plaque"],"prefix":"10.3389","volume":"8","author":[{"given":"Xueyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhua","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangwen","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingbo","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1161\/01.CIR.100.9.903","article-title":"Process of progression of coronary artery lesions from mild or moderate stenosis to moderate or severe stenosis: a study based on four serial coronary arteriograms per year","volume":"100","author":"Yokoya","year":"1999","journal-title":"Circulation."},{"key":"B2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/1573399052952550","article-title":"Endothelial dysfunction in hyperglycemia as a trigger of atherosclerosis","volume":"1","author":"Nakagami","year":"2005","journal-title":"Curr Diabetes Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"S419","DOI":"10.1016\/S0002-8703(99)70266-8","article-title":"Atherosclerosis is an inflammatory disease","volume":"138","author":"Ross","year":"1999","journal-title":"Am Heart J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1161\/CIRCRESAHA.117.305637","article-title":"Do plaques rapidly progress prior to myocardial infarction? The interplay between plaque vulnerability and progression","volume":"117","author":"Ahmadi","year":"2015","journal-title":"Circ Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"C13","DOI":"10.1016\/j.jacc.2005.10.065","article-title":"Pathology of the vulnerable plaque","volume":"47","author":"Virmani","year":"2006","journal-title":"J Am Coll Cardiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1161\/01.CIR.0000087480.94275.97","article-title":"From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I","volume":"108","author":"Naghavi","year":"2003","journal-title":"Circulation."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1161\/01.ATV.20.5.1262","article-title":"Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions","volume":"20","author":"Virmani","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1160\/TH10-12-0784","article-title":"Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) Working Group on atherosclerosis and vascular biology","volume":"106","author":"Yla-Herttuala","year":"2011","journal-title":"Thromb Haemost."},{"key":"B9","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1242\/jcs.115.14.2817","article-title":"Elastic fibres","volume":"115","author":"Kielty","year":"2002","journal-title":"J Cell Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1172\/JCI200420641","article-title":"Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome","volume":"114","author":"Judge","year":"2004","journal-title":"J Clin Invest."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/eurheartj\/ehu041","article-title":"Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death","volume":"36","author":"Van der Donckt","year":"2015","journal-title":"Eur Heart J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1161\/ATVBAHA.116.306874","article-title":"Do the Apoe-\/- and Ldlr-\/- mice yield the same insight on atherogenesis?","volume":"36","author":"Getz","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1136\/hrt.2008.143461","article-title":"Animal models and potential mechanisms of plaque destabilisation and disruption","volume":"95","author":"Ni","year":"2009","journal-title":"Heart."},{"key":"B14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s11883-002-0025-3","article-title":"Animal models of spontaneous plaque rupture: the holy grail of experimental atherosclerosis research","volume":"4","author":"Rosenfeld","year":"2002","journal-title":"Curr Atheroscler Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/01.ATV.0000060200.73623.F8","article-title":"Rupture of the atherosclerotic plaque: does a good animal model exist?","volume":"23","author":"Cullen","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1161\/CIRCULATIONAHA.109.872663","article-title":"Impaired fibrillin-1 function promotes features of plaque instability in apolipoprotein E-deficient mice","volume":"120","author":"Van Herck","year":"2009","journal-title":"Circulation."},{"key":"B17","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1089\/dna.2014.2480","article-title":"Shear stress in atherosclerotic plaque determination","volume":"33","author":"Li","year":"2014","journal-title":"DNA Cell Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.jacc.2008.12.056","article-title":"Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage","volume":"53","author":"Sluimer","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2015.11.083","article-title":"Arterial stiffness, atherosclerosis and cardiovascular risk: Pathophysiologic mechanisms and emerging clinical indications","volume":"77","author":"Palombo","year":"2016","journal-title":"Vascul Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/HCO.0000000000000179","article-title":"Arterial stiffness and coronary artery disease","volume":"30","author":"Ikonomidis","year":"2015","journal-title":"Curr Opin Cardiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/08037050701428166","article-title":"The pulsatile component of blood pressure: its role in the pathogenesis of atherosclerosis","volume":"16","author":"Jankowski","year":"2007","journal-title":"Blood Press."},{"key":"B22","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1161\/CIRCRESAHA.115.304634","article-title":"Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis","volume":"115","author":"Feil","year":"2014","journal-title":"Circ Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2010.05.013","article-title":"Carotid plaque formation and serum biomarkers","volume":"213","author":"Hermus","year":"2010","journal-title":"Atherosclerosis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1056\/NEJM199906173402418","article-title":"Atherosclerosis\u2013an inflammatory disease","volume":"340","author":"Weissberg","year":"1999","journal-title":"N Engl J Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3969\/j.issn.1007-3949.2019.04.006","article-title":"Research progress on the role of inflammatory response in vulnerable plaque and its mechanism","volume":"27","author":"Qin","year":"2019","journal-title":"Chin J Arterioscler"},{"key":"B26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/nrcardio.2014.173","article-title":"Macrophage subsets in atherosclerosis","volume":"12","author":"Chinetti-Gbaguidi","year":"2015","journal-title":"Nat Rev Cardiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.3390\/ijms20071722","article-title":"Crude alpha-mangostin suppresses the development of atherosclerotic lesions in apoe-deficient mice by a possible M2 macrophage-mediated mechanism","volume":"20","author":"Shibata","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/01.ATV.0000251503.35795.4f","article-title":"Biomarkers of atherosclerotic plaque instability and rupture","volume":"27","author":"Koenig","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1189\/jlb.0602325","article-title":"The many faces of macrophage activation","volume":"73","author":"Mosser","year":"2003","journal-title":"J Leukoc Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/S0008-6363(03)00516-9","article-title":"Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome","volume":"59","author":"Jones","year":"2003","journal-title":"Cardiovasc Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1161\/res.90.3.251","article-title":"Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly","volume":"90","author":"Galis","year":"2002","journal-title":"Circ Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.2174\/1568026611208011192","article-title":"Matrix metalloproteinases in acute coronary syndromes: current perspectives","volume":"12","author":"Kampoli","year":"2012","journal-title":"Curr Top Med Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1172\/JCI117619","article-title":"Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques","volume":"94","author":"Galis","year":"1994","journal-title":"J Clin Invest."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1161\/01.ATV.0000090126.34881.B1","article-title":"Induction of atherosclerosis by low-fat, semisynthetic diets in LDL receptor-deficient C57BL\/6J and FVB\/NJ mice: comparison of lesions of the aortic root, brachiocephalic artery, and whole aorta (en face measurement)","volume":"23","author":"Teupser","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1172\/JCI116663","article-title":"Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery","volume":"92","author":"Ishibashi","year":"1993","journal-title":"J Clin Invest."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e35835","DOI":"10.1371\/journal.pone.0035835","article-title":"Hyperlipidemia and atherosclerotic lesion development in Ldlr-deficient mice on a long-term high-fat diet","volume":"7","author":"Ma","year":"2012","journal-title":"PLoS ONE."},{"key":"B37","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00109-004-0631-3","article-title":"The key role of apolipoprotein E in atherosclerosis","volume":"83","author":"Greenow","year":"2005","journal-title":"J Mol Med (Berl)."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3390\/ijms17091511","article-title":"Molecular imaging of vulnerable atherosclerotic plaques in animal models","volume":"17","author":"Gargiulo","year":"2016","journal-title":"Int J Mol Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejphar.2017.05.010","article-title":"Animal models of atherosclerosis","volume":"816","author":"Emini","year":"2017","journal-title":"Eur J Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.4070\/kcj.2019.0211","article-title":"Understanding vulnerable plaques: current status and future directions","volume":"49","author":"Lee","year":"2019","journal-title":"Korean Circ J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1161\/ATVBAHA.111.239335","article-title":"Relationships between recent intraplaque hemorrhage and stroke risk factors in patients with carotid stenosis: the HIRISC study","volume":"32","author":"Turc","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"11574","DOI":"10.3390\/ijms160511574","article-title":"Vasa vasorum in atherosclerosis and clinical significance","volume":"16","author":"Xu","year":"2015","journal-title":"Int J Mol Sci."},{"key":"B43","first-page":"542","article-title":"Research advance of outer membrane vasa vasorum in atherosclerotic vulnerable plaque","volume":"2019","author":"Qi","year":"2019","journal-title":"Chin J Arterioscler."},{"key":"B44","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1080\/07853890.2017.1366041","article-title":"Role of lipids and intraplaque hypoxia in the formation of neovascularization in atherosclerosis","volume":"49","author":"Chistiakov","year":"2017","journal-title":"Ann Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/cells9020336","article-title":"Prolonged hyperoxygenation treatment improves vein graft patency and decreases macrophage content in atherosclerotic lesions in ApoE3*Leiden mice","volume":"9","author":"Parma","year":"2020","journal-title":"Cells."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1007\/s40279-018-0996-z","article-title":"Oxidative stress and inflammation, key targets of atherosclerotic plaque progression and vulnerability: potential impact of physical activity","volume":"48","author":"Mury","year":"2018","journal-title":"Sports Med."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.642751\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T05:32:55Z","timestamp":1619674375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.642751\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,16]]},"references-count":46,"alternative-id":["10.3389\/fcvm.2021.642751"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.642751","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,16]]},"article-number":"642751"}}